News|Articles|March 2, 2005
- Pharmaceutical Technology-03-02-2005
- Volume 29
- Issue 3
A “Disclosure Defense” in Liability Law
In this time of liability reform, pharma deserves the chance to align its economic interests with its ethical obligations to the patient.
Advertisement
Articles in this issue
over 21 years ago
March 2005over 21 years ago
Packaging Becomes Part of the Prescriptionover 21 years ago
Appraisal of the Laser Diffraction Particle-Sizing Techniqueover 21 years ago
Optimism Taking Over in Pharmaceutical Chemicalsover 21 years ago
In the Spotlight - March 2005over 21 years ago
Managing Aseptic Interventionsover 21 years ago
Validating Automated Systemsover 21 years ago
Combination Products Raise Manufacturing ChallengesAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Activity Round Up – July 2026
2
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
3
Midyear 2026 Check-In: Agentic AI Cuts Deviation Investigations by 50%
4
EMA and EU Innovation Agency Deepen Ties to Speed Up Drug Development
5